A recent finding in Nature showed that the spike protein of SARS-CoV-2 binds with fibrinogen, leading to thrombo-inflammation. This raises a fundamental question: Why does the virus need to bind with ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

The discovery, published in the journal Cell, has sparked global interest due to its similarities to SARS-CoV-2, the virus ...

The new virus, emerging in Wuhan, China, is called SARS-CoV-2 and is responsible for the disease known as COVID-19. SARS-CoV-2 spread quickly around the globe. Unlike SARS-CoV or MERS-CoV, SARS-CoV-2 ...

For all the mysteries that remain about the novel coronavirus and the COVID-19 disease it causes, scientists have generated an incredible amount of fine-grained knowledge in a surprisingly short time.

“I thought, ‘What can I do for the next 20 or 30 years?’” He found an answer in SARS-CoV-2, the virus responsible for the COVID-19 pandemic, that was rapidly spreading around the worl ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants ...

COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...